Transdermal delivery system
AssigneeBen-Gurion University of the Negev Research and Development Authority
InventorsAmnon Sintov, Uri Wormser
Life of this patent
Estimating the term…
Abstract
A transdermal delivery system comprising an active ingredient selected from the group consisting of peptides, proteins and mixtures thereof and a pharmaceutically acceptable oxidizing agent. The transdermal delivery system is an easy-to-use topical system that facilitates the penetration of an active ingredient, such as insulin, through the skin layers and into the blood stream. Additionally, the invention includes a method for treating diabetes and other pathologic systemic conditions comprising administering an active ingredient selected from the group consisting of peptides, proteins and mixtures thereof and a pharmaceutically acceptable oxidizing agent.
Claims5
A transdermal delivery system for treating diabetes and insulin influenced pathologic systemic conditions comprising insulin and a pharmaceutically acceptable oxidizing agent selected from the group consisting of permanganate and silver protein, said oxidizing agent enabling and facilitating the penetration of said active ingredient through the skin layers and into the blood stream.
A transdermal delivery system for treating diabetes and insulin influenced pathologic systemic conditions comprising insulin and buthionine sulfoximine.
Dependencies are inferred from the claim text.